Nyfosa distributed to the ordinary shareholders in Hemfosa and listed on Nasdaq Stockholm

The shares in Nyfosa AB have today been admitted to trading on Nasdaq Stockholm, Large Cap. The listing is a first step for Nyfosa as a stand-alone company following the distribution to the holders of ordinary shares in Hemfosa Fastigheter AB.

On 13 September 2018, an extraordinary general meeting of Hemfosa resolved to distribute all of the shares in the subsidiary Nyfosa to the holders of ordinary shares in Hemfosa. The purpose of having two independent and specialized companies is to create better conditions for leveraging the potential of the entire business and thus increase shareholder value. On 30 September 2018, Nyfosa had properties with a total property value of SEK 15.4 billion. Please refer to www.nyfosa.se.  

Hemfosa and Nyfosa were advised by Cederquist in connection with the separation, distribution and listing of Nyfosa. Cederquist’s team consisted mainly of Fredrik Lundén, Elin Ljungström, Linn Ejderhamn, Louise Génetay and Björn Sjöberg (Equity Capital Markets), Michela Westin, Babak Morad Bakhti and Oskar Ceréus (Real Estate), Johan Lundberg and Kajsa Morawetz (Financing), Jonas Forsén (Corporate & Commercial) and several other employees.